For nearly two decades, the Eye Center of Northern Colorado has committed to providing patients access to the latest investigational drugs and devices through participation in clinical trials. These clinical trials have helped make significant strides in the understanding of eye diseases and how to better treat them.
Our doctors and patients have participated in over 70 clinical trials resulting in FDA approval of more than a dozen new medications and technologies as well as contributing to greater medical knowledge in the field of Ophthalmology. These advancements have gone on to improve medical care for millions of patients in the US and around the world.
LEARN MORE ABOUT OUR CLINICAL TRIALS
If you would like more information about participating in a clinical trial please contact our research department at:
Courtney Moon
Research Department Manager
We are currently enrolling patients in the following studies.
Glaucoma & Ocular Hypertension
- Travoprost Intraocular Implant (iDose)
- Study description on clinicaltrials.gov
- Hydrus Microstent for Refractory Open-Angle Glaucoma
- Hydrus Microstent with Cataract Surgery Post-Approval
- Study description on clinicaltrials.gov
Retina
- Ranibizumab Port Delivery System (PDS)
- Study description on clinicaltrials.gov
PAST CLINICAL TRIALS
Eye Center of Northern Colorado is privileged to have worked with many drugs and devices that went on to gain FDA approval and are now used to treat patients every day. Some of these technologies include:
Cataract
- Acrysof Restor IOL
- Acrysof High Toric
- IQ Vivity IOL
Glaucoma
- Glaukos iStent
- Xen Shunt
- Glaukos iStent Inject
- Glaukos G2-W
- Hydrus Microstent
- Rhopressa
- Simbrinza
Presbyopia
- Kamra Inlay
Inflammation
- Inveltys
- TobraDex
- Nevanac